Alternative

ZEISS Receives US FDA Approval for VisuMax SMILE Vision Correction Procedure, the Latest Advancement in Laser Eye Surgery

JENA, GERMANY and DUBLIN, CA: ...

BioSyent Named to the PROFIT 500 Ranking of Canada''s Fastest-Growing Companies With a Five-Year Revenue Growth Rate of 815%

TORONTO, ONTARIO: ...

Medifirst Solutions Announces Shareholder Update

FREEHOLD, NJ: Medifirst Continues to Ramp Up for Sales ...

Arch Therapeutics Provides Corporate Update at the 18th Annual Rodman & Renshaw Global Investment Conference

FRAMINGHAM, MA: ...

The Alliance for Regenerative Medicine Submits Comments in Response to FDA Draft Guidances on the Regulation of Human Cells, Tissues or Cellular or Tissue-Based Products

WASHINGTON, DC: ...

Mettrum Announces Stock Options Grants

TORONTO, ONTARIO: ...

Fennec to Present at Rodman & Renshaw 18th Annual Global Investment Conference in New York on September 13, 2016

RESEARCH TRIANGLE PARK, NORTH CAROLINA: ...

Opexa Therapeutics to Present at Rodman & Renshaw 18th Annual Global Investment Conference

THE WOODLANDS, TX: Final Patient Visit Completed in Phase 2b Clinical Trial of Tcelna (imilecleucel-T) in Secondary Progressive Multiple Sclerosis; Top-Line Results Expected in Early Q4 2016 ...

Cannabis Science Receives Initial Batch of Nebulizers for CBIS MDI Rescue Inhalers Targeting Asthma/COPD; Prepares Packaging & Distribution

IRVINE, CA: ...

New Research From Kantar Health Shows High BMI Is Less of a Factor for Developing Diabetes

SINGAPORE: Majority of Type 2 Diabetes Patients in Japan Are Not Overweight ...